Evidence map›Paper›PMID 42756751›Full record

ReviewFrontiers in pharmacology2026

Vitamin D in male reproduction: molecular mechanisms and pharmacological perspectives.

Jing Liu, Bang Liu, Xingyun Qiu, Mengmei Lv, Shasha Liu, Dai Zhou

Abstract readReview
In one paragraph

Review in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jing Liu *Hunan Provincial Key Laboratory of Regional Hereditary Birth Defect Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan, China.
Bang Liu *Hunan Provincial Key Laboratory of Regional Hereditary Birth Defect Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan, China.
Xingyun QiuThe Third School of Clinical Medicine, Ningxia Medical University, Yinchuan, Ningxia, China.
Mengmei LvHunan Provincial Key Laboratory of Regional Hereditary Birth Defect Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan, China.
Shasha LiuHunan Provincial Key Laboratory of Regional Hereditary Birth Defect Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan, China.
Dai ZhouHunan Provincial Key Laboratory of Regional Hereditary Birth Defect Prevention and Control, Changsha Hospital for Maternal & Child Health Care Affiliated to Hunan Normal University, Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D has attracted increasing attention in male reproduction, male fertility, and sperm function, but its pharmacological relevance remains incompletely defined. This review synthesizes current evidence on the molecular mechanisms and clinical implications of vitamin D signaling in the male reproductive system. Available experimental and human data suggest that the vitamin D receptor (VDR) and vitamin D-metabolizing enzymes are present in testicular cells, the epididymis, accessory sex glands, and mature spermatozoa, supporting the possibility of both systemic and local actions. Mechanistically, vitamin D may regulate sperm capacitation and progressive motility through calcium-dependent non-genomic pathways. Ligand-activated VDR signaling may also contribute to antioxidant defense, mitochondrial stability, inflammatory control, steroidogenesis, germ-cell survival, and epigenetic regulation, although several of these pathways still require direct validation in human testicular tissue and spermatozoa. Clinically, low circulating 25-hydroxyvitamin D has been most consistently associated with impaired sperm motility, whereas associations with sperm concentration, total sperm count, reproductive hormones, and sperm DNA fragmentation index are less consistent. Interventional studies suggest that vitamin D supplementation may improve selected semen parameters in deficient men, but current trials do not support broad endocrine or fertility benefits in unselected populations. Importantly, emerging preclinical data indicate that excessive vitamin D exposure may impair spermatogenesis, highlighting a potential biphasic relationship in which both deficiency and excess are unfavorable. Thus, vitamin D should be viewed as a homeostatic modulator rather than a stand-alone treatment for male infertility. Future studies should define optimal therapeutic windows, clarify effects on sperm DNA integrity, and incorporate individual differences in VDR-related genetic and epigenetic regulation.

Indexed as

male reproductionmolecular pharmacologyoxidative stresssperm motilityvitamin Dvitamin D receptor (VDR)

Identifiers

PMID42756751
PMCPMC13583599

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.